aptamers
The EU has awarded the researchers €188,000 to support the project through September 2026, by which time they hope to have a validated prototype ready.
Aptamer Group Inks £465K Deal With Timser Group for Cervical Cancer Test Reagents
Aptamer Group will develop a set of its aptamer-based Optimer binders for Timser's blood-based cervical cancer biomarker panel.
Aptamer Group, Neuro-Bio Partner on Lateral Flow Test for Alzheimer's Disease
The test will use affinity agents developed by Neuro-Bio in a lateral flow assay targeting the T14 peptide, which Neuro-Bio hopes to validate as an Alzheimer's marker.
Achiko Secures $1.3 Million Financing to Support Production of DNA Aptamer Test for COVID-19
The new financing follows a marketing and sales agreement and the CE marking of a saliva-based rapid antigen test that uses a DNA aptamer to detect COVID-19.
Achiko Obtains CE Mark, IVDR Registration for Aptamer-Based COVID-19 Antigen Test
The Swiss firm's saliva-based rapid test is read by an ultraviolet spectrophotometer and uses a DNA aptamer instead of an antibody to detect COVID-19.